CD19

An insight into novel third-generation TLR2 co-stimulatory CAR-T cells 1:13
An insight into novel third-generation TLR2 co-stimulatory CAR-T cells
Yasmin Nouri • 9 Feb 2023
Direct detection and isolation of CAR cells from patient samples 1:27
Direct detection and isolation of CAR cells from patient samples
Saskia Rösch • 6 Apr 2022
DSG3-CAART: A novel CAAR T-cell therapy in pemphigus vulgaris 2:23
DSG3-CAART: A novel CAAR T-cell therapy in pemphigus vulgaris
Samik Basu • 26 Jan 2022
Mechanisms of resistance to CAR T-cell therapies 5:09
Mechanisms of resistance to CAR T-cell therapies
John Rossi • 26 Aug 2021
NKX019 in B-cell malignancies 1:05
NKX019 in B-cell malignancies
Kanya Rajangam • 13 Oct 2021
Exciting advances in CAR-T and TCR research 2:49
Exciting advances in CAR-T and TCR research
David Gilham • 22 Feb 2021
Developing CAR T-cell therapy for HIV 4:37
Developing CAR T-cell therapy for HIV
Marco Alessandrini • 20 May 2021
Challenges of CAR T-cell therapy for AML: is CD38 the answer? 6:10
Challenges of CAR T-cell therapy for AML: is CD38 the answer?
Lei Yu • 3 Jun 2021
Horizon scanning in anti-CD19 CAR T-cell therapy 3:07
Horizon scanning in anti-CD19 CAR T-cell therapy
Marco Alessandrini • 20 May 2021
CAR-NKs for B cell malignancies 2:09
CAR-NKs for B cell malignancies
James Trager • 10 Mar 2021
CAR T-cells in adult ALL 4:13
CAR T-cells in adult ALL
Arnon Nagler • 1 Feb 2021
Progression of CAR-T trials in China 2:19
Progression of CAR-T trials in China
Jianxiang Wang • 2 Feb 2021
CAR-T trials to watch in China 3:21
CAR-T trials to watch in China
Jianxiang Wang • 2 Feb 2021
The content of VJRegenMed is intended for healthcare professionals